Professor Hollander graduated with a 1st Class degree in Pharmacology from The University of Bath and a PhD in Pathology from the University of Bristol. He then spent three years at an internationally renowned cartilage laboratory at McGill University in Montreal before returning to the UK to take up an Arthritis Research UK Fellowship and a Lectureship at The University of Sheffield. He was appointed as the Arthritis Research UK Professor of Rheumatology and Tissue Engineering at the University of Bristol in September 2000 and he was Head of The School of Cellular and Molecular Medicine in Bristol from 2009 - 2013. He was appointed as Head of The Institute of Integrative Biology and Professor of Stem Cell Biology at The University of Liverpool in June 2014 and as Associate Pro-Vice-Chancellor (Enterprise) in 2016.
Clinical & Research interests
Professor Hollander has over 100 publications and he has received approximately £7 million of peer-reviewed funding over the past 10 years from The UK government, medical charities, the EU framework programmes and from biotechnology companies. He has been the named inventor on several patents. He is co-founder and Scientific Director of a spin-out company, Azellon Cell Therapeutics and through the company is currently running a World’s first clinical trial of a “Cell Bandage” for the treatment of torn knee cartilage.
In his previous roles, Professor Hollander contributed to undergraduate teaching on BSc and MBChB programmes, including lectures on stem cell biology and cartilage regeneration. He has also trained numerous postgraduate students on MSc, PhD and MD programmes.